Quarterly report pursuant to Section 13 or 15(d)

Derivative Liabilities and Financial Instruments (Tables)

v3.21.1
Derivative Liabilities and Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Level 2 Valuation Financial Instruments

The Company had not derivative liabilities at March 31, 2021 or December 31, 2020. For the three months ended March 31, 2020, a roll-forward of the level 2 valuation financial instruments is as follows:

 

    Derivative Liabilities  
Balance at December 31, 2019   $ 400,139  
Recognition of derivative liabilities upon initial valuation     415,000  
Change in fair value of derivative liabilities during the three months ended March 31, 2020     (135,139 )
         
Balance at March 31, 2020   $ 680,000